StockWatch
·

MAHINDRA & MAHINDRA FINANCIAL SERVICES LTD.

BSE: 532720

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
5.2K
+4.0%+15.3%
Expenditure
4.0K
+5.9%+7.2%
Net Profit
881.52
-1.9%+54.8%
OPM %
69.55%
-0.48pp+5.15pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.001.4K2.9K4.3K5.8KQ1 FY19Q2 FY19Q3 FY19Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Q2 FY27 shareholding: promoter stake fell over 0.5 pts in 130 companies; mutual funds rose that much in 276

shareholding pattern · Q2 FY27 · promoter holding

ResearchDeep dive14 Nov 20269 min

The 61% PAT Pop That Masks a Margin Squeeze

AUM growth · credit cost · cost of funds

Result verdictFollow-upQ2 FY2727 Oct 20266 minFinancial Services

Strong YoY growth, but QoQ PAT slips amid rate headwinds

AUM growth · credit cost stable · rate hikes

TranscriptDeep diveQ2 FY2727 Oct 20266 minFinancial Services
Latest
Quarterly Result21 Oct, 5:50 pm

Mahindra Finance: Consolidated PAT Jumps 61% YoY to ₹911 Cr, NPM Expands to 15.3%

Mahindra & Mahindra Financial Services posted consolidated PAT of ₹910.73 Cr for Q2 FY27, up 60.9% YoY from ₹566.07 Cr a year ago, on consolidated revenue from operations of ₹5,935.66 Cr, up 18.1% YoY from ₹5,026.19 Cr. Standalone PAT came in at ₹881.52 Cr (EPS ₹6.34) against consolidated EPS of ₹6.54; YoY profit growth was somewhat stronger at the consolidated level (+60.9%) than standalone (+54.8%), a gap consistent with scale-up at housing-finance subsidiary MRHFL ahead of its planned April 2027 merger into the parent. Sequentially, PAT eased 1.8% QoQ from Q1 FY27's ₹927.48 Cr even as revenue grew 3.8% QoQ — a mild step-down after Q1's exceptional 75% YoY profit jump, which the pre-result preview had flagged as a tough comparison to sustain. This quarter's slower-but-still-strong 61% YoY print reads as normalization rather than deterioration, with NPM still expanding to 15.28% from 11.21% a year ago (versus 16.20% in Q1, so a touch of sequential margin give-back). The YoY margin expansion was driven by a lower provisioning load relative to book growth: half-year impairment on financial instruments came in at ₹1,195.82 Cr, which annualizes to roughly 1.6% of the average loan book (₹1,46,017.84 Cr) — comfortably within management's guided 1.3-1.7% through-cycle credit-cost band. Finance costs rose to ₹2,523.00 Cr for the quarter from ₹2,197.68 Cr a year ago as the balance sheet grew (total assets to ₹1,80,291.69 Cr from ₹1,58,643.94 Cr at FY26-end), but revenue growth outpaced the rise in cost of funds, letting operating leverage flow through. No exceptional items hit either the current or year-ago quarter, so the 60.9% YoY PAT growth is a clean, unadjusted figure. Against our pre-result preview (PAT ~₹850-950 Cr, revenue ~₹5,700-5,900 Cr), the print landed inline — PAT at ₹910.73 Cr sat mid-band and revenue at ₹5,935.66 Cr came in marginally above the top of the guided range. No independent brokerage consensus PAT estimate turned up in search beyond the preview itself; Street positioning (60.6% Buy rating, ₹350 median target versus a pre-result price of ₹319.45) centered on execution risk around the MRHFL merger and sustaining 20%+ disbursement growth — both of which this quarter's 22% YoY disbursement growth (to ₹16,490 Cr, per the company's October 2 business update) and the board's merger clearance help address. Standalone gross Stage-3 came in at 3.42% (net 1.51%, PCR 56.64%), within the pre-flagged 3.35-3.45% range, confirming asset quality held up as expected; collection efficiency wasn't separately disclosed in this filing, so the previewed 97% figure couldn't be independently verified. The quarter also saw ₹2,000 Cr and ₹1,250 Cr NCD raises (the latter at a 7.95% fixed coupon) and a steady-to-improved ESG rating, neither of which shows up directly in this quarter's P&L. No standalone press release commentary was available to extract management's own framing of the quarter. Against the FY26-31 guidance from the July 2026 call (16-18% CAGR, credit cost 1.3-1.7%, ROA progressing to 2.5%, no capex for 6-8 quarters), the quarter tracks on-plan: credit cost at ~1.6% annualized sits mid-band, and annualized ROA (PAT run-rate over average total assets) works out to roughly 2.1-2.2% — still below the 2.5% target but consistent with the "progressing to" framing rather than a miss. The items to watch into H2 FY27 are whether PAT growth normalizes further toward the ~22% disbursement growth rate as Q1's high base fully laps, and how MRHFL integration and NCLT approval timelines affect the P&L ahead of the April 1, 2027 appointed date.

21 Oct 2026, 05:50 pm

Corporate Events

Board MeetingM&MFIN
2026
11Nov

Board Meeting

The Debenture Issuance Committee, authorized by the Board of…

BSE Filing ↗
Board MeetingM&MFIN
2026
21Oct

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingM&MFIN
2026
24Sep

Board Meeting

The Debenture Issuance Committee, authorized by the Board of…

BSE Filing ↗
Board MeetingM&MFIN
2026
5Aug

Board Meeting

The Board of Directors considered and approved the Scheme of…

BSE Filing ↗
Board MeetingM&MFIN
2026
21Jul

Board Meeting

The 36th Annual General Meeting ("AGM") of the Company will …

BSE Filing ↗
DividendM&MFIN
2026
13Jul

₹7.5 / share

BSE Filing ↗
DividendM&MFIN
2025
15Jul

Dividend

BSE Filing ↗
Board MeetingM&MFIN
2025
2May

Board Meeting

Fund raise by way of offer and issuance of fully paid-up equ…

BSE Filing ↗
Board MeetingM&MFIN
2025
22Apr

Board Meeting

Update .... (Listing Obligations and Disclosure Requirements…

BSE Filing ↗
Board MeetingM&MFIN
2024
22Oct

Board Meeting

Consideration and approval of the Financial Results for Q2 F…

BSE Filing ↗
Board MeetingM&MFIN
2024
23Jul

Board Meeting

Consideration and approval of financial results for Q1 FY 20…

BSE Filing ↗
DividendM&MFIN
2024
16Jul

₹6.3 / share

BSE Filing ↗
DividendM&MFIN
2024
4May

₹6.3 / share

BSE Filing ↗
Board MeetingM&MFIN
2024
4May

Board Meeting

Consider and approve the audited standalone and consolidated…

BSE Filing ↗